In the Netherlands 4-7% of children have asthma. In some cases, an asthma attack can develop that is potentially life-threatening and results in children needing to be admitted to an intensive care unit (ICU). The Asthma Project seeks to develop a programme aimed at prevention of asthma attacks and to establish a dosing schedule for the drug Salbutamol which has a scientific basis. The Asthma Project is a multicenter clinical trial. This furthers the cooperation of the various child IC departments in the Netherlands. Ammodo supports the Asthma Project to encourage research into the treatment of asthma in children.